News February 2025
Smivet BV continues to grow as we have started to expand the team, project portfolio, IP and B2B collaborations. More news to follow about applying the strength of single-domain antibodies in medicinal products for Animal Health.
Smivet BV continues to grow as we have started to expand the team, project portfolio, IP and B2B collaborations. More news to follow about applying the strength of single-domain antibodies in medicinal products for Animal Health.